Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

This publication has 29 references indexed in Scilit:

• Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction
  Journal of Applied Physiology, 2000
• Inhibitory Regulation of Hypertrophy by Endogenous Atrial Natriuretic Peptide in Cultured Cardiac Myocytes
  Hypertension, 2000
• Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts
  British Journal of Pharmacology, 1998
• Comparison of Atrial Natriuretic Peptide Versus Nitroglycerin for Reducing Blood Pressure in Acute Myocardial Infarction
  The American Journal of Cardiology, 1998
• Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
  Circulation, 1994
• Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells.
  Endocrinology, 1993
• Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location.
  Circulation, 1988
• Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
  Journal of Clinical Investigation, 1986
• Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure.
  Circulation, 1985
• Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations.
  Circulation, 1979